Moderna
MRNA
#1636
Rank
NZ$17.22 B
Marketcap
$44.54
Share price
-7.18%
Change (1 day)
-73.53%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$17.22 Billion

As of April 2025 Moderna has a market cap of NZ$17.22 Billion. This makes Moderna the world's 1636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$17.22 B-37.11%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Apr 3rd, 2025 the market cap of Moderna was reported to be:

NZ$17.18 Billion
by Nasdaq info icon info icon
NZ$17.22 Billion
by CompaniesMarketCap info icon info icon
NZ$17.22 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.20 B-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$377.76 B 2,093.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.44 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$58.73 B 241.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$383.82 B 2,128.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$2.86 B-83.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$666.71 B 3,771.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.15 B-70.07%๐Ÿ‡บ๐Ÿ‡ธ USA